Evaluation of two chemical coadjuvants in the treatment of chronic periodontitis
Phase 2
- Conditions
- Periodontal DiseaseK05.6
- Registration Number
- RBR-98wrmb
- Lead Sponsor
- Centro Universitário Cesmac
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients systemically healthy, older than 18 years and younger than 60 years of age, able to read and sign the WICF and diagnosed with chronic periodontal disease.
Exclusion Criteria
Patients with any pathology that negatively influence tissue healing (eg diabetes mellitus), pregnant and lactating, allergic to adjuvants that are used in the research, and smokers.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic effect of 2.5% melaleuca gel in the treatment of chronic periodontal disease in systemically healthy patients is equal to or greater than 1% Chlorhexidine.;It is intended to evaluate the therapeutic effect of 2.5% melaleuca gel in the treatment of chronic periodontal disease in systemically healthy patients through its comparison with the<br>therapeutic effect of 1% chlorhexidine gel
- Secondary Outcome Measures
Name Time Method Adverse effects of 1% chlorhexidine and 2.5% melaleuca gel on pouch irrigation in the treatment of chronic peridontitis in systemically healthy patients;To evaluate the incidence of adverse effects arising from the use of chemical adjuvants (chlorhexidine 1% and Melaleuca 2.5%) in the form of gel for irrigation of periodontal pockets in a single dose